Triheptanoin: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Triheptanoin. Educational only — not medical advice.
Labeled uses
DOJOLVI is indicated as a source of calories and fatty acids for the treatment of adult and pediatric patients with molecularly confirmed long-chain fatty acid oxidation disorders (LC-FAOD).
Source: FDA labeling via NIH DailyMed (set 4cfeb8bd…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.